Qualifications
Key Responsibilities:Lead the design and execution of diagnostic strategies from registration through to launch for various clinical studies and molecule programs.Oversee the development, outsourcing, and validation of clinically relevant in vitro diagnostic assays throughout the lifecycle of our molecules, ensuring effective collaboration with internal and external stakeholders.Provide strategic expertise to development teams, ensuring access to cutting-edge diagnostic technologies (e.g., NGS-based tissue and ctDNA assays, PCR, immunohistochemistry) and addressing any technical or statistical challenges related to companion diagnostics.Manage the implementation of clinical trial assays at CRO laboratories to support clinical studies, ensuring timely adaptations to study scope, budgets, and agreements.Facilitate joint development initiatives between Revolution Medicines and diagnostic partners, ensuring alignment on development, regulatory, and commercialization strategies for effective CDx development.
About the job
Revolution Medicines stands at the forefront of precision oncology, dedicated to pioneering targeted therapies aimed at disrupting critical pathways in RAS-addicted cancers. Our innovative R&D pipeline features RAS(ON) Inhibitors that target a variety of oncogenic RAS protein variants, alongside RAS Companion Inhibitors intended for use in synergistic treatment combinations. As a valued member of the Revolution Medicines team, you'll collaborate with a group of passionate professionals committed to transforming the lives of patients with RAS pathway mutations.
The Opportunity:
Join Revolution Medicines as the Associate Director of Companion Diagnostics within our Translational Medicine function. This pivotal role within our Precision Medicine Companion Diagnostics team offers a unique opportunity to lead global diagnostic strategies that support the development and commercialization of our groundbreaking therapies. The ideal candidate will thrive in a dynamic, collaborative environment and play an integral role in multidisciplinary project teams.
About Revolution Medicines
Revolution Medicines is a pioneering clinical-stage biotechnology firm focused on precision oncology. We are driven by an unwavering commitment to develop innovative therapies that specifically target the nuances of RAS-addicted cancers. Our collaborative approach and cutting-edge research aim to redefine cancer treatment and improve patient outcomes.